Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
about
Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells.A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasionSpecific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contextsACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate.The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP InhibitionC-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model.Understanding the temporal sequence of genetic events that lead to prostate cancer progression and metastasis.Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation.PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.Novel effects of Helicobacter pylori CagA on key genes of gastric cancer signal transduction: a comparative transfection study.Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion.Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.Overexpression of MCPH1 inhibits the migration and invasion of lung cancer cells.The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer CellsETV4: an emerging target in pancreatic cancer
P2860
Q27853114-B5AADC97-D21E-4442-BFF2-3C39347F8B2BQ33682955-5490F1C0-C3B5-41A1-AF1F-627E5E32E45FQ33884597-E228D409-6788-405A-94F9-05932B8CDFCCQ35741647-0CECBFDF-2010-4092-8E3C-0450B1DD7AE1Q35801707-9B00DBDB-1777-4B28-8183-D67CC6B27218Q35930506-AE942EDA-614B-464C-B769-837663536A9CQ36413690-08F25401-79D2-42C2-87DE-FEB4EABDC6D4Q37173154-FBA71D27-68E3-4234-AD5F-871D28597EE8Q38747762-21CA21D8-0A0D-41AB-9C3F-AE7B663A7368Q38779478-4D348C8A-E899-4CA9-A815-FD17C9B87658Q38846778-3C67CD60-8EE0-4AB4-A4ED-7DD6D5104472Q38903196-1B850C68-15B5-4EBC-B833-A0F1013A4B5EQ42052829-E8B6CD62-4EC2-428F-92CE-CB3D8B1661ADQ47374122-85525E11-51EB-45CC-9E5F-CFCE10B38582Q47424104-3CC697DA-9A34-4053-B48C-354222F9B203Q49678212-0BCD72E7-3B66-4FB5-9E36-931B7DF523C9Q55101765-9656C92C-67BB-4330-A4F4-9FB782488C17Q57150715-CABBDD7D-91FA-4A73-8A06-6915849B083FQ59128426-60D80141-2C0B-472B-8571-278CB3A1C6D2
P2860
Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Overexpression of ETV4 is onco ...... lial to mesenchymal transition
@ast
Overexpression of ETV4 is onco ...... lial to mesenchymal transition
@en
type
label
Overexpression of ETV4 is onco ...... lial to mesenchymal transition
@ast
Overexpression of ETV4 is onco ...... lial to mesenchymal transition
@en
prefLabel
Overexpression of ETV4 is onco ...... lial to mesenchymal transition
@ast
Overexpression of ETV4 is onco ...... lial to mesenchymal transition
@en
P2093
P2860
P50
P356
P1433
P1476
Overexpression of ETV4 is onco ...... lial to mesenchymal transition
@en
P2093
A Pellecchia
C Pescucci
E De Lorenzo
P2860
P2888
P356
10.1038/ONCSIS.2012.20
P577
2012-07-16T00:00:00Z